Libertatem Magazine

Uttarakhand High Court Issues Notice to Baba Ramdev’s Patanjali

Contents of this Page

The Uttarakhand High Court issued notices to Baba Ramdev’s Patanjali. Union and State Governments are seeking a reply within a week on the firms Coronil drug.

Brief Facts of the Case

On June 23, Baba Ramdev had announced ‘Coronil’ and ‘Swasari’ as a cure for coronavirus. For this, they claim that they have conducted a clinical case study and a clinical controlled trial. They also found that 69% of patients recovered in 3 days and 100 patients recovered in 7 days”.

Therefore, the Uttarakhand High Court issued notices to Patanjali, NIMS, Jaipur and ICMR. The Company have collaborated with another company to give a reply in a week on a PIL. The PIL alleges that founders of Patanjali, Baba Ramdev and Acharya Balkrishna claimed to have found ayurvedic medicine, Coronil for curing Coronavirus. But, they had not sought any permission from the concerned authorities about the same.

Petitioner’s Plea

Advocate Mani Kumar is representing the petitioner. The petitioner who filed this petition has sought a ban on the drug made by Patanjali. They also accuse Baba Ramdev of misleading people by launching Coronil as a medicine to cure Covid-19. The PIL stated that Patanjali claims that NIMS University has tested the drug. But the institute denied it. The PIL has also contended that the drug neither has the certification of the Indian Council of Medical Research (ICMR) nor does Patanjali have the license to manufacture it.

Court’s Decision

Hearing a PIL challenging Baba Ramdev’s claims about the medicine, a division bench of Chief Justice Ramesh Ranganathan and Justice R C Khulbe issued the notices.

The Union AYUSH Ministry said the company can sell Coronil in the market as an immunity
booster. But not as medicine for coronavirus and now they are only calling it a product to
“manage” the disease. is now on Telegram. Follow us for regular legal updates and judgements from the court. Follow us on Google News,InstagramLinkedInFacebook & Twitter. You can also subscribe for our Weekly Email Updates. You can also contribute stories like this and help us spread awareness for a better society. Submit Your Post Now.

About the Author